Dymon Asia Capital (Singapore)’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,250	Closed	-$266K	–	71
2021 Q4	$266K	Sell	8,250 -8,250	-50%	-$266K	0.03%	43
2021 Q3	$737K	Buy	16,500 +7,952	+93%	+$355K	0.08%	35
2021 Q2	$323K	Buy	+8,548	New	+$323K	0.03%	32